Literature DB >> 7807024

Inhibition of tumor growth by elimination of granulocytes.

L A Pekarek1, B A Starr, A Y Toledano, H Schreiber.   

Abstract

As observed for many types of cancers, heritable variants of ultraviolet light-induced tumors often grow more aggressively than the parental tumors. The aggressive growth of some variants is due to the loss of a T cell-recognized tumor-specific antigen; however, other variants retain such antigens. We have analyzed an antigen retention variant and found that the variant tumor cells grow at the same rate as the parental tumor cells in vitro, but grew more rapidly than the parental cells in the T cell-deficient host. The growth of the variant cells was stimulated in vitro by factors released from tumor-induced leukocytes and by several defined growth factors. In addition, the variant cancer cells actually attracted more leukocytes in vitro than the parental cells. Furthermore, elimination of granulocytes in vivo in nude mice by a specific antigranulocyte antibody inhibited the growth of the variant cancer, indicating that this tumor requires granulocytes for rapid growth.

Entities:  

Mesh:

Year:  1995        PMID: 7807024      PMCID: PMC2191807          DOI: 10.1084/jem.181.1.435

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  A significant part of macrophage-derived growth factor consists of at least two forms of PDGF.

Authors:  K Shimokado; E W Raines; D K Madtes; T B Barrett; E P Benditt; R Ross
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

2.  Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes.

Authors:  D M Lewinsohn; R F Bargatze; E C Butcher
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

3.  Antigenicity of murine skin tumors induced by ultraviolet light.

Authors:  M L Kripke
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

4.  Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor.

Authors:  A Baird; P Mormède; P Böhlen
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

5.  Expression and secretion of type beta transforming growth factor by activated human macrophages.

Authors:  R K Assoian; B E Fleurdelys; H C Stevenson; P J Miller; D K Madtes; E W Raines; R Ross; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

6.  Molecular cloning of gene sequences regulated by platelet-derived growth factor.

Authors:  B H Cochran; A C Reffel; C D Stiles
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

7.  Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.

Authors:  J H Sisson; S M Prescott; T M McIntyre; G A Zimmerman
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

8.  Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.

Authors:  J L Lasky; N M Ponzio; G J Thorbecke
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

Review 9.  Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.

Authors:  D P Dialynas; D B Wilde; P Marrack; A Pierres; K A Wall; W Havran; G Otten; M R Loken; M Pierres; J Kappler
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

10.  Resistance of human tumor cells in vitro to oxidative cytolysis.

Authors:  J O'Donnell-Tormey; C J DeBoer; C F Nathan
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

View more
  124 in total

1.  Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies.

Authors:  E Barbera-Guillem; K F May; J K Nyhus; M B Nelson
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 2.  Targeting stroma to treat cancers.

Authors:  Boris Engels; Donald A Rowley; Hans Schreiber
Journal:  Semin Cancer Biol       Date:  2011-12-24       Impact factor: 15.707

3.  Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.

Authors:  Anna Song; Wankyu Eo; Sookyung Lee
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

4.  Arresting supporters: targeting neutrophils in metastasis.

Authors:  Swarnali Acharyya; Joan Massague
Journal:  Cell Res       Date:  2016-01-29       Impact factor: 25.617

5.  In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site.

Authors:  Jessica M Haverkamp; Scott A Crist; Bennett D Elzey; Cansu Cimen; Timothy L Ratliff
Journal:  Eur J Immunol       Date:  2011-02-02       Impact factor: 5.532

Review 6.  Advancements in immune tolerance.

Authors:  Ping-Ying Pan; Junko Ozao; Zuping Zhou; Shu-Hsia Chen
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

7.  The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis.

Authors:  Courtney A Cohen; Amanda A Shea; C Lynn Heffron; Eva M Schmelz; Paul C Roberts
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-10

8.  The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci.

Authors:  Sally A DuPré; Doug Redelman; Kenneth W Hunter
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

Review 9.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 10.  The dual role of complement in cancer and its implication in anti-tumor therapy.

Authors:  Ioannis Kourtzelis; Stavros Rafail
Journal:  Ann Transl Med       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.